ストックスクリーナーアプリを入手
0.44
16.44%
0.0701
前日終値:
$0.3699
開ける：
$0.3693
24時間の取引高:
561.75K
Relative Volume:
0.33
時価総額：
$27.95M
収益：
$361.07M
当期純損益:
$-71.54M
株価収益率:
-0.557
EPS:
-0.79
ネットキャッシュフロー:
$-47.97M
1週間 パフォーマンス:
+44.10%
1か月 パフォーマンス:
+93.23%
6か月 パフォーマンス:
-13.86%
1年 パフォーマンス:
-79.19%
1日の値動き範囲:
$0.36
$0.44
1週間の範囲:
$0.2519
$0.44
52週間の値動き範囲:
$0.1253
$2.45
Oncology Institute Inc Stock (TOI) Company Profile
TOI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
0.44 | 27.95M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
308.25 | 77.46B | 69.62B | 5.93B | 5.88B | 22.27 |
|
DVA
Davita Inc
|
162.51 | 14.21B | 12.67B | 827.68M | 1.42B | 9.27 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.77 | 13.29B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
THC
Tenet Healthcare Corp
|
130.19 | 12.47B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
185.95 | 12.15B | 15.42B | 1.03B | 956.84M | 15.02 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-02-26 | 再開されました | Jefferies | Buy |
| 2022-09-14 | 開始されました | Guggenheim | Buy |
| 2022-08-15 | 開始されました | Jefferies | Buy |
Oncology Institute Inc (TOI) 最新ニュース
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection - Business Wire
The Oncology Institute Inc WT (TOIIW-Q) QuotePress Release - The Globe and Mail
HighTower Advisors LLC Has $27,000 Stock Position in The Oncology Institute, Inc. (NASDAQ:TOI) - Defense World
Oncology Institute faces potential Nasdaq delisting - Investing.com
Florida Blue enhances cancer care for thousands of members - The Manila Times
Florida Blue Launches Breakthrough Cancer Care Program with The Oncology Institute Partnership - StockTitan
Brian Druker resigns as OHSU Knight Cancer Institute CEO - The Business Journals
Oncology institute director Brad Hively acquires $50,000 in stock - Investing.com
Oncology institute director Brad Hively acquires $50,000 in stock By Investing.com - Investing.com UK
Despite Recent Gains, Oncology Institute Insiders Are Still Down US$110k - Simply Wall St
Grapevine Saves The Oncology Institute Millions On Healthcare Supplies - Markets Insider
Oncology Institute Inc (NASDAQ: TOI): Blank Check For Growth? - Stocks Register
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx's Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial - The Manila Times
RenovoRx Expands Phase III Pancreatic Cancer Trial with Major Cancer Institute Partnership - StockTitan
Oncology Institute Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.19 loss in 3Q 2023) - Yahoo Finance
The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2024 Earnings Call Transcript - Insider Monkey
USF and TGH partner with robotics company to become the first to bring life-saving surgical technology to Tampa Bay - University of South Florida
Earnings call: The Oncology Institute reports strong growth in Q3 2024 - Investing.com
Oncology Institute Reports Strong Revenue Growth Amid Challenges - TipRanks
The Oncology Institute, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
The Oncology Institute Reports Third Quarter 2024 Financial Results - The Manila Times
Oncology Institute Q3 Revenue Jumps 22% to $99.9M Despite Margin Pressure | TOI Stock News - StockTitan
Oncology Institute Announces Board Changes for 2025 - TipRanks
Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib - BioSpace
The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California - The Manila Times
Oncology Institute (TOI) Launches Groundbreaking Outpatient Cancer Treatment Service | TOI Stock News - StockTitan
The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call - ForexTV.com
Los Angeles Cancer Network Continues Growth Spurt With New Hope Cancer Institute Acquisition - PR Newswire
Cancer Care - WellSpan Health
Bayhealth welcomes new hematologist oncologist to cancer institute - CapeGazette.com
GlycoMimetics, Inc. Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint - Marketscreener.com
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint - Business Wire
The Oncology Institute Joins Lantern's Cancer Care Network of Excellence - The Manila Times
The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence - GlobeNewswire
Steven K. Libutti, MD, FACS, Named Inaugural William N. Hait Director at Rutgers Cancer Institute - RWJBarnabas Health
The American Journal of Managed Care® and The Oncology - GlobeNewswire
The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care - StockTitan
Verismo Therapeutics Announces the Activation of its CELESTIAL-301 Clinical Trial at Colorado Blood Cancer Institute - PR Newswire
TOIIWThe Oncology Institute, Inc. Warrant Latest Stock News & Market Updates - StockTitan
The Oncology Institute of Hope & Innovation Launches Oregon Market - GlobeNewswire
IGI Announces CRADA with National Cancer Institute to Test - GlobeNewswire
Cancer Care | Plantation - Baptist Health South Florida
The Oncology Institute Announces CFO Changes - Marketscreener.com
Logos Global Management LP Takes $14.30 Million Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Promising Progress in Oncology as Cancer Deaths Decline and Research Grows - Baystreet.ca
Nomic® and Parker Institute for Cancer Immunotherapy (PICI) Launch Large-Scale Protein Profiling to Investigate Immunotherapy Responses in RADIOHEAD Study - Business Wire
Farallon Capital Management LLC Sells 729,200 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - MarketBeat
The Oncology Institute announces chief financial officer transition - Yahoo Finance
Circassia Pharmaceuticals Announces Share Buyback - TipRanks
Circassia Pharmaceuticals Announces Strong H1 2024 Results - TipRanks
Oncology Institute Inc (TOI) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
1.17%
大文字化:
|
ボリューム (24 時間):